Navigation Links
Pioneer Award recipients Marina Cavazzana and Adrian Thrasher recognized for advancing gene therapy to the clinic for immunodeficiency disorders
Date:3/24/2014

New Rochelle, NY, March 24, 2014Marina Cavazzana, MD, PhD, Paris Descartes University, France and Adrian J. Thrasher, MD, PhD, University College London Institute of Child Health, UK, have been honored with the Pioneer Award for basic and clinical gene therapy for immunodeficiency disorders. Human Gene Therapy, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers, is commemorating its 25th anniversary by bestowing this honor on the leading 12 Pioneers in the field of cell and gene therapy selected by a blue ribbon panel* and publishing a Pioneer Perspective by the award recipients

Dr. Cavazzana has been at the forefront of advances in treating life-threatening inherited diseases of the immune system with gene therapy, using a patient's own modified stem cells. She describes the translation of this work to the clinic and its ongoing advances and novel applications in the article "Hematopoetic Stem Cell Gene Therapy: Progress on the Clinical Front." The article by Dr. Cavazzana is available free on the Human Gene Therapy website at http://online.liebertpub.com/doi/full/10.1089/hum.2014.2504.

A pioneer of gene therapy in the UK, Dr. Thrasher has been at the leading edge of basic science research on the function of therapeutic genes for inherited disorders and the development of viral vectors to deliver them to affected patients. He has collaborated on gene therapy clinical trials targeting immunodeficiency disorders with groups in Europe and the USA.

"Cell therapy and gene therapy are advancing together to improve patient care," says Dr. Cavazzana. "We can expect to be able to rebuild a new immune system not only in primary immunodeficiencies but also in severe acquired clinical conditions (such as those in HIV-1-infected patients)."

"I've seen some very exciting times in the field, from the first evidence that biochemical defects can be corrected in vitro, to some remarkable clinical successes in patients with devastating diseases. I look forward with huge enthusiasm to the exciting developments on the horizon, which are likely to impact on more patients with an even wider range of disorders," says Dr. Thrasher.

"These pioneers contributed to the first real clinical successes of gene therapy through their work in inherited immune deficiency disorders," says James M. Wilson, MD, PhD, Editor-in-Chief of Human Gene Therapy, and Director of the Gene Therapy Program, Department of Pathology and Laboratory Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia.


'/>"/>
Contact: Vicki Cohn
vcohn@liebertpub.com
914-740-2100
Mary Ann Liebert, Inc./Genetic Engineering News
Source:Eurekalert  

Related biology news :

1. Joseph Glorioso, Ph.D., receives Pioneer Award
2. OU professor recognized by AAAS for pioneering efforts to advance ecological forecasting
3. Ronald Crystal, M.D., receives Pioneer Award
4. David Allis, pioneer in epigenetics, to receive prestigious Japan Prize
5. Pioneering path to electrical conductivity in tinker toy materials to appear in Science
6. Top 12 Pioneer Awards for seminal work in gene and cell therapy selected by blue ribbon panel
7. Biometrics Pioneer DERMALOG Awarded German Foreign Trade Prize
8. 2 online science video pioneers combine to form new iBiology.org
9. Pioneers in Alzheimers research: Research couple honored for its lifetime achievement
10. Oxfords Gero Miesenböck is awarded The Brain Prize 2013 for his pioneering work on optogenetics
11. Manchester patients take part in pioneering heart attack blood test trial
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Pioneer Award recipients Marina Cavazzana and Adrian Thrasher recognized for advancing gene therapy to the clinic for immunodeficiency disorders
(Date:11/12/2019)... ... November 12, 2019 , ... The Arnold and Mabel Beckman ... research institutions for its Instrumentation Grant for Advanced Light-Sheet Microscopy and Data ... site for the acquisition of instrumentation, development and maintenance; support for data science ...
(Date:11/9/2019)... BOISE, Idaho (PRWEB) , ... November 08, 2019 , ... ... GPK Acquisitions as a new client and user of SiteSeer. The boutique ... six acres across the U.S. will use SiteSeer to supplement its own analysis of ...
(Date:11/6/2019)... ROCHELLE, Va. (PRWEB) , ... November 06, 2019 ... ... announced today that Donald Stanski, MD, a senior pharmaceutical industry executive with expertise ... modeling and simulation for drug and disease strategic data analytics, has joined the ...
Breaking Biology News(10 mins):
(Date:11/6/2019)... BEDFORD, Mass. (PRWEB) , ... November 06, 2019 , ... ... tons of whole pieces of fruits and vegetables per hour to improve processing. , ... the rate of multiple tons per hour to increase juice yields by up to ...
(Date:11/5/2019)... ... November 05, 2019 , ... Focal Healthcare , ... for its Fusion Bx 2.0 prostate fusion biopsy solution. By combining information from ... 2.0 will give urologists across Europe the ability to perform targeted transrectal and ...
(Date:11/2/2019)... ... October 31, 2019 , ... Join Patrick Raber, ... live webinar on Friday, November 15, 2019 at 1pm EST to ... science of profiling T-cell receptors (TCRs) and B-cell receptors (BCRs), has been widely ...
(Date:10/30/2019)... , ... October 30, 2019 , ... ... to showcase the many roles innovation and technology play in educating the next ... Innovation, featured hands-on learning opportunities and presentations by WesternU administrators and representatives of ...
Breaking Biology Technology: